Literature DB >> 24136568

Factors affecting outcomes of corneal collagen crosslinking treatment.

I Toprak1, V Yaylalı2, C Yildirim3.   

Abstract

PURPOSE: To assess the effects of preoperative patient characteristics on clinical outcomes of corneal crosslinking (CXL) treatment in patients with progressive keratoconus.
METHODS: This retrospective study comprised 96 eyes of 96 patients who had unilateral CXL treatment for progressive keratoconus. All patients underwent a complete ophthalmological examination and corneal topography at baseline and 1 year. Subgroup analyses were performed according to the age (<30 and ≥ 30 years), gender, preoperative corrected distance visual acuity (CDVA, <0.3 and ≥ 0.3 logMAR (log of the minimum angle of resolution)), preoperative maximum keratometry (K, <54 and ≥ 54 D), baseline topographic cone location (central, paracentral, and peripheral), and preoperative thinnest pachymetry (<450 and ≥ 450 μm) to determine the associations between preoperative patient characteristics and outcomes (changes in visual acuity and maximum keratometry) of CXL treatment.
RESULTS: In the entire study population, mean CDVA and maximum K significantly improved after CXL treatment (P<0.001). Patients with a preoperative CDVA of 20/40 Snellen equivalent or worse (≥ 0.3 logMAR) experienced more visual improvement after CXL treatment (P<0.001). However, an age ≥ 30 years and a baseline thinnest pachymetry less than 450 μm were found significantly associated with more flattening in maximum keratometry (P=0.024, P=0.005 respectively). Gender, preoperative maximum K, and baseline topographic cone location did not show significant effect on postoperative visual acuity and maximum keratometry (P>0.05).
CONCLUSIONS: In patients with progressive keratoconus, age, baseline visual acuity, and baseline thinnest pachymetry seem to affect the success of the CXL treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136568      PMCID: PMC3890756          DOI: 10.1038/eye.2013.224

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  23 in total

1.  Increased resistance of crosslinked cornea against enzymatic digestion.

Authors:  Eberhard Spoerl; Gregor Wollensak; Theo Seiler
Journal:  Curr Eye Res       Date:  2004-07       Impact factor: 2.424

2.  Mean visual acuity.

Authors:  J T Holladay; T C Prager
Journal:  Am J Ophthalmol       Date:  1991-03-15       Impact factor: 5.258

3.  Comparison of central corneal thickness measurements by rotating Scheimpflug camera, ultrasonic pachymetry, and scanning-slit corneal topography.

Authors:  Shiro Amano; Norihiko Honda; Yuki Amano; Satoru Yamagami; Takashi Miyai; Tomokazu Samejima; Miyuki Ogata; Kazunori Miyata
Journal:  Ophthalmology       Date:  2006-06       Impact factor: 12.079

Review 4.  Keratoconus.

Authors:  Y S Rabinowitz
Journal:  Surv Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 6.048

5.  Corneal thickness measurements with the Orbscan Topography System and ultrasonic pachymetry.

Authors:  V Yaylali; S C Kaufman; H W Thompson
Journal:  J Cataract Refract Surg       Date:  1997-11       Impact factor: 3.351

6.  Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus.

Authors:  David P S O'Brart; Tsong Q Kwong; Parul Patel; Robert J McDonald; Naomi A O'Brart
Journal:  Br J Ophthalmol       Date:  2013-02-05       Impact factor: 4.638

Review 7.  Keratoconus and related noninflammatory corneal thinning disorders.

Authors:  J H Krachmer; R S Feder; M W Belin
Journal:  Surv Ophthalmol       Date:  1984 Jan-Feb       Impact factor: 6.048

8.  Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study.

Authors:  Aldo Caporossi; Stefano Baiocchi; Cosimo Mazzotta; Claudio Traversi; Tomaso Caporossi
Journal:  J Cataract Refract Surg       Date:  2006-05       Impact factor: 3.351

9.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

10.  Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2003-09       Impact factor: 3.351

View more
  20 in total

1.  The efficacy of standard versus accelerated epi-off corneal cross-linking protocols: a systematic review and sub-group analysis.

Authors:  Mohammad Miraftab; Hassan Hashemi; Mohammad Abdollahi; Shekoufeh Nikfar; Soheila Asgari
Journal:  Int Ophthalmol       Date:  2019-06-20       Impact factor: 2.031

2.  Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up.

Authors:  Darren Shu Jeng Ting; Romeela Rana-Rahman; Yunzi Chen; Dugald Bell; Jean-Pierre Danjoux; Stephen J Morgan; Saurabh Ghosh; Oliver Baylis
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

3.  Comment on, 'Factors affecting outcomes of corneal collagen crosslinking treatment'.

Authors:  P Vinciguerra; V Romano; M R Romano; C Azzolini; R Vinciguerra
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

4.  Response to Vinciguerra et al.

Authors:  I Toprak; V Yaylalı; C Yildirim
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

5.  Iontophoresis-assisted corneal crosslinking using 0.1% riboflavin for progressive keratoconus.

Authors:  Hong-Zhen Jia; Xu Pang; Zheng-Jun Fan; Na Li; Gang Li; Xiu-Jun Peng
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

6.  Long-term results of accelerated and conventional corneal cross-linking.

Authors:  Samara Barbara Marafon; Sergio Kwitko; Diane Ruschel Marinho
Journal:  Int Ophthalmol       Date:  2020-06-13       Impact factor: 2.031

7.  Predictive Factors of the Standard Cross-linking Outcomes in Adult Keratoconus: One-Year Follow-Up.

Authors:  Amani E Badawi; Waleed Ali Abou Samra; Ayman Abd El Ghafar
Journal:  J Ophthalmol       Date:  2017-08-29       Impact factor: 1.909

8.  Outcomes of corneal crosslinking for central and paracentral keratoconus.

Authors:  Mingxia Tian; Ping Ma; Weiyan Zhou; Jie Feng; Guoying Mu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 9.  Patient selection for corneal collagen cross-linking: an updated review.

Authors:  Virgilio Galvis; Alejandro Tello; Alvaro I Ortiz; Luis C Escaf
Journal:  Clin Ophthalmol       Date:  2017-04-07

10.  Predictors for treatment outcomes after corneal crosslinking for keratoconus: a validation study.

Authors:  Daniel A Godefrooij; Kim Boom; Nienke Soeters; Saskia M Imhof; Robert P L Wisse
Journal:  Int Ophthalmol       Date:  2016-05-24       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.